Cargando…
The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma
BACKGROUND: Malignant mesothelioma is a rare cancer with poor outcome, associated with asbestos exposure. Reactive oxygen species may play an important role in the mechanism of carcinogenesis; therefore, genetic variability in antioxidative defence may modify an individual’s susceptibility to this c...
Autores principales: | Franko, Alenka, Kotnik, Nika, Goricar, Katja, Kovac, Viljem, Dodic-Fikfak, Metoda, Dolzan, Vita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter Open
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839088/ https://www.ncbi.nlm.nih.gov/pubmed/29520212 http://dx.doi.org/10.2478/raon-2018-0004 |
Ejemplares similares
-
Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma
por: Goričar, Katja, et al.
Publicado: (2015) -
Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Zupanc, Cita, et al.
Publicado: (2021) -
Evaluation of Soluble Mesothelin-related Peptides and MSLN Genetic Variability in Asbestos-related Diseases
por: Goricar, Katja, et al.
Publicado: (2020) -
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases
por: Franko, Alenka, et al.
Publicado: (2020) -
Soluble Mesothelin-Related Peptides Levels in Patients with Malignant Mesothelioma
por: Franko, Alenka, et al.
Publicado: (2012)